ArticleOncoimmunology2015

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib.

Paul J Neeson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.